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Externality exists in healthcare when an individual benefits from
others being healthy as it reduces the probability of getting sick
from illness. Healthy workers are considered to be the more
productive labourers leading to a country’s positive economic
growth over time. Several research studies have modelled
disease transmission and its economic impact on a single
country in isolation. We developed a two-country disease-
economy model that explores disease transmission and cross-
border infection of disease for its impacts. The model includes
aspects of a worsening and rapid transmission of disease
juxtaposed by positive impacts to the economy from tourism.
We found that high friction affects the gross domestic product
(GDP) of the lower-income country more than the higher-
income country. Health aid from one country to another can
substantially help grow the GDP of both countries due to
the positive externality of disease reduction. Disease has less
impact to both economies if the relative cost of treatment over
an alternative (e.g. vaccination) is lower than the baseline
value. Providing medical supplies to another country,
adopting moderate friction between the countries, and finding
treatments with lower costs result in the best scenario to
preserve the GDP of both countries.
1. Introduction
Diseases of poverty include infectious diseases such as
tuberculosis (TB), malaria and HIV/AIDS, as well as diseases
stemming from malnutrition. Poverty is a main social
determinant of health in developing countries and diseases of
poverty are often correlated with malnutrition [1]. It was
estimated that diseases of poverty account for almost half of the
© 2021 The Authors. Published by the Royal Society under the terms of the Creative
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burden of diseases in countries with the highest poverty rates. Despite being manageable with existing
treatments and often preventable, diseases of poverty exact an enormous amount of mortality and
morbidity toll on the populations in low-income countries [2].
Labour participation and productivity of a country are determined by the interaction of the
population’s exposure to diseases and how it impacts human capital accumulation over time. Previous
studies have shown that low-income countries, when compared with high-income countries, have less
income to spend on disease risk management efforts to control disease transmission and reduce
incidence. Infectious diseases affect the ability of individuals to work and reduces the productivity of
the country’s overall human capital [3].
High-income countries possess infrastructure, training and the ability to build disease surveillance
capacity for a new disease if it is lacking. Epidemiology with contact and case tracing can inform
appropriate resource allocation by using the evidence base from health-related incidents in a
population. Surveillance and epidemiology allow for rapid response to disease occurrence, recurrence,
the number of incidents and the rate at which the disease transmits within the population.
Epidemiological evidence helps to inform disease risk management policies used by risk managers
and to evaluate the efficacy of programmes and intervention policies [4].
A poverty trap refers to conditions that may trap individuals, groups and whole economies in
intractable poverty. Also, poverty is considered one of the greatest risk factors for acquiring endemic
infectious diseases. The resulting chronic morbidities and co-morbidities act to reduce human capital
and hamper efforts to escape diseases of poverty, and results in an ongoing poverty trap. There are
various research studies addressing the insidious cycle between prevalence of diseases and the
occurrence of poverty traps [5,6]. Economic and epidemiological conditions are indicators of the overall
health and socio-economic growth potential of the population, so the poverty trap can be weakened by
action that enhances the health status of the population [5]. Disease and poverty have a constant,
nonlinear relationship and there is a significant link between the infectious diseases of poverty and
poverty-related conditions like the lack of sanitation and nutrition that make people more vulnerable to
infections and diseases in general. A recent study showed the relationship between death from non-
communicable disease (NCD) and poverty [7]. Health is an important element of economic prosperity
and we only need to look at the perpetual poverty of African countries and the prevalence of endemic
diseases to understand the negative impacts. Diseases such as malaria cause an externality affecting
human capital and it alsomay be a factor that contributes to disease persistence and economic decline [8,9].
The term externality is defined in a number of ways. Externality is a result when an agent produces or
consumes a good or service that causes a cost or benefit on other parties who are not involved in this
transaction [10]. In terms of disease spread, it could be identified through people’s risk of infection
due to other people’s behaviours [11]. An externality can be both positive and negative, as in the form
of a benefit or cost. An economic approach of unpaid environmental impacts on production and
consumption that influence the cost and utility of consumers over market functioning comes under
environmental externalities. Whereas, disease externalities begin from an individual’s action while
adopting prevention and treatment of infectious disease that finally affects others in terms of their
health and choices. At the population level, externalities can be reduced by implementing
interventions, such as taxes, subsidies and new measures.
Many researchers have studied infectious disease usingmodelling and economics, but these are often done
in isolation [12–14]. A few research studies have shown the impacts from infectious diseases on a country’s
economy but remain focused largely on the dynamics within the country, in isolation from other
populations [15–18]. However, there are conditions under which a country’s economy can be severely
affected by health choices that are adopted by individuals of another country due to externalities. For
example, the recent COVID-19 pandemic has highlighted how individual country choices to limit the
movement of goods and people both within and between countries has affected, in part, the timing,
introduction, and severity of the outbreaks from travel-related transmissions of SARS-CoV-2 [19].
It is well known that poor people in low-income countries suffer from higher rates of illness,
particularly infectious diseases and malnutrition due to several factors including little food, unclean
water, low levels of sanitation and shelter, lack of infrastructure to deal with high exposure to
infectious agents and lack of appropriate medical care [20]. Research has confirmed that addressing
determinants of health can yield significant sustainable returns for improving population health [21].
The ability of the healthcare system to provide effective services can be strengthened by various types
of health aid such as training (increasing the availability of adequate skilled healthcare workers, e.g.
nurses, doctors), infrastructure (essential equipment, supplies, health facilities) and medicines (such as







































focuses on the provision of health aid given in the form of vaccines as an example. This health aid
addresses and manages longer-term transmissible disease impacts in the context of our model where
externality is caused by the movement of infected people between two countries.
We developed a disease transmission model within and between two hypothetical, neighbouring
countries and show its impact on the gross domestic product (GDP). Under our simulations, a non-
specific infection is shown entering the country where it becomes endemic circulating within the
population repeatedly. For example, a non-specific infection could be a disease of poverty such as
tuberculosis (TB), which has been circulating in India for at least a few hundred years [22]. We
explore how mobility between countries and communities can affect the respective economies through
disease transmission and how health aids can help to break the effects of the externality. If we
consider that a number of adults within a country become infected from a disease then it can
drastically affect the GDP of that country. If one country gets the disease, then another country may
restrict travel completely as a way of preventing the importation of cases. Prolonged travel restrictions
between countries can exert a negative effect decreasing the GDP of both countries. The optimal
situation may be obtained by providing adequate health aid to another country, such as building
surveillance capacity, medical supplies, antivirals and vaccines, while attempting to mitigate the
transmission of the disease or prevent the disease transmission and protect its GDP.
2. Model and methods
2.1. Modelling disease and economic growth
Our model introduces a two-country disease-economy coupled system of differential equations. The
coupled system is used to study an infectious disease starting in country 1 and its epidemiological
and economic repercussions on country 2, and then back on itself due to cross-border infection. In
particular, we consider that the two exclusively interacting countries are initially at two different
socio-economic levels and of different population sizes. Disease spreads internally in country 1 and is
transmitted to country 2 and then back to country 1 due to the mutual interaction of citizens (e.g.
visitation such as tourism) modelled using the gravity model of trade [23]. At the same time,
visitation adds to the economy growth of the destination country [23].
We consider both non-mandatory vaccination and treatment interventions for the disease to be
available and in turn their degree of use affects the GDP. Also, some infected individuals are not
considered as part of the working labour force due to extended illness, especially at high GDP levels.
Treatment can decrease the length of the illness time period. People voluntarily choose to be vaccinated
based on their perception of risk of the disease, and it is assumed to be proportional to disease prevalence
and outcomes [24].
Important for understanding the interaction of disease and its cross-border infection, we study the
effect of health aid on the disease and economic progress in both countries if health aid from country
2 into country 1 is implemented. Health aid in our scenarios is represented by the parameter A
defined as the number of vaccines subsidized per year by country 2 for country 1, during the
existence of the disease in country 1.
We use a pair of disease models based on a susceptible-infected-recovered (SIR) model (see appendix A)
d
dt




yi ¼ xiðli,iyi þ li,jy jÞ  gið1þ LiÞyi  miyi ð2:2Þ
for i = 1, 2 and j = 2, 1; The diseasemodel is coupledwith a pair of economic growthmodels (Solowmodel) of
the per capita GDP ($1000) given by the equation (see appendix A)
d
dt




for i = 1, 2 and j = 2, 1. The two systems start initially at y1(0) > 0, y2(0) = 0, k1(0), and k2(0) are at different levels.







































respectively. The variables ki and li are the per capita GDP ($1000) and fraction of labour to population
size of country i, respectively. Birth and death rates are given as μi and νi, see appendix B. Recovery
rate and transmission rates are given as γi and λi,j. Treatment relatively increases the recovery rate by Li.
All of the parameters μi, νi, γi, λi,j, Li functionally depend on ki, see appendix B. The probability of
vaccination is pi = θp yi as a rule-of-thumb for the decision to get vaccinated. The rate of capital
accumulation due to production and visitation are given as σi and σi,j. The parameter αi is the constant of
elasticity in the Cobb–Douglas form of production with constant to returns scale and δi is the depreciation
rate. T(ki, Ni; kj, Nj) is the gravity function of country j into the country i based on per capita GDP,
population sizes and friction.
The model also includes the cost of vaccination cV(t) and treatment cT(t). The cost of treatment is a τ
multiple of the cost of vaccination cT(t) = τ∗cV(t). Since the disease evolution and development process are
modelled in a time frame of decades, we use an inflation factor for the cost of vaccination with a rate f.
Finally, ℓ(k) is the proportion of infected individuals who are available for work, probably as a result of
the difficulty to have a paid leave of absence due to low GDP. A full account of derivation of equations
(2.1)–(2.3) and their parameters are given in appendices A and B.
We use birth and death rates that are dependent on the socio-economic status of the countries based on
estimates similar to those made previously [25]. Disease transmission and recovery rates are dependent
on the socio-economic status of the two countries through sanitation and nutrition, respectively, that
were also previously estimated [25], (see also appendix B for adjustments that we made to these rates).
The basic transmission rate β0 is the maximum transmission rate achievable at zero (practically, very
low) GDP. It is a multiplication of the basic contact rate λ0 and the probability of transmission ρ0 upon
contact when there is no sanitation at all. The basic recovery rate γ0 is the maximum recovery rate
achievable for an infinite (practically, very large) GDP due to high nutrition levels, see appendix B. The
basic treatment effect L0 is the maximum physiologically possible relative increase in the recovery rate
achievable for an infinite (practically, very large) GDP due to better medical care infrastructure, see
appendix B.
We also examine the effect of health aid on the economy of both countries by comparing the cost of
vaccination and treatment against subsidizing vaccination in country 1. This could be done by
introducing a number of compulsory vaccines subsidized per year, A, by country 2 for country 1
whenever the disease exists. Thus, the equation describing the rate of change in x1 becomes
d
dt
x1 ¼ m1ð1 x1Þ  p1x1  Iðy1.0ÞA=N1  x1ðl1,1y1 þ l1,2y2Þ, ð2:4Þ
and the equation describing the rate of change in k2 becomes
d
dt
k2 ¼ s2ka22 l1a22  ðd2 þ m2  n2Þk2  cVðtÞ  ððp2x2 þ Iðy1.0ÞA=N2Þ þ t  ðg2L2y2ÞÞ: ð2:5Þ
2.2. Model calibration
We used available tuberculosis (TB) data (of all types) from Mexico and the USA, from 1990 to 2010, to
calibrate the model parameters [26]. Here, we use Mexico and the USA as examples for calibrating the
model with N1(0) = 87 065 000 and N2(0) = 248 709 873, respectively. We fitted the time series of
infections and i GDP ($1000) to the model’s simulation. (While this is in no way an actual estimation
of model parameters, we use the best-fit parameters values as a starting point for the analyses.) We
used weighted sums of squares of errors as the objective function in the minimization problem.
We implemented the minimization process using the genetic algorithm function available in
Matlab. We used the calibration process to find initial values of per capita GDP k1(0) = 3.112 per
100 000, k2(0) = 23.889 per 100 000, and prevalence I1(0) = 16.78 per 100 000, and I2(0) = 11.325
per 100 000. The list of parameters that were found through calibration and the values are given in
table 1. Other parameters discussed in appendix B were fitted to actual data from external sources like
Gapminder.com. See appendix C for results of model calibration and parameter values.
2.3. Model analysis
We let the per capita GDP ki(t) and prevalence yi(t) be represented as functions in a vector parameter θ,
and denote them by ki(t; θ) and yi(t; θ), respectively. As a measure in the change of the course of the














































































































































































































































































































































































































































































































































































































































































































































































































































































































p. 340). In particular, we use two measures defined on the curve of simulation X(t; θ); e.g. per capita GDP





for the vector of parameters θ. We also define the ratio of the areas under the curves at two vector values
of the parameters θ1 and θ2 to be
RAUCðXju1, u2Þ ¼ AUCðXju2ÞAUCðXju1Þ :
We use a time window of a century, T = 100, as the base for our investigation.














































































































































































































































































































































































Figure 1. Simulation of externality and cross-border infection of diseases for different degrees of contagiousness when both
countries are initially equally sized. Simulations of GDP (in $1000) and disease prevalence for country 1 (a,c,e) and country 2
(b,d,f ) when an epidemic starts in country 1 with 10 initial cases, τ = 1000 and N1(0) = N2(0) = 10
7. The three rows of
figures are simulations with (a,b) k1(0) = 9, and k2(0) = 55; (c,d ) k1(0) = 9, k2(0) = 9, and σ2 = σ1 = 0.224; and (e,f ) k1(0) =







































Integrals are numerically calculated using the trapezoid rule. The integrands are solutions of the
ordinary differential equation (ODE) system, which are also solved numerically using the Runge–
Kutta method. All numerical procedures are implemented using Matlab.
3. Results
3.1. Model simulation
We ran simulations of the model to investigate the effect of some important parameters on the externality
and cross-border infection on both countries. We let the basic transmission rate be an r multiple of the
calibrated value in table 1; that is, β0 = 0.46r for r≥ 1. In the following simulations, we examined the
effects of the initial economy status, population size, friction and cost of treatment on the disease
















































































































































































































































































































































































































































Figure 2. Simulation of externality and cross-border infection of diseases for different degrees of contagiousness when both
countries are initially not equally sized. Simulations of GDP (in $1000) and disease prevalence for country 1 (a,c,e) and country
2 (b,d,f ) when an epidemic starts in country 1 with 10 initial cases, τ = 1000, N1(0) = 10
7 and N2(0) = 10
8. The three rows of
figures are simulations with (a,b) k1(0) = 9, and k2(0) = 55; (c,d ) k1(0) = 9, k2(0) = 9, and σ2 = σ1 = 0.224; and (e,f ) k1(0) =







































spread within and between the two countries and the induced change in economy. We then examined
the counter-effect of health aid on the disease and economy.
Throughout the simulations, the disease spreads differently in both countries, but the qualitative
features of the epidemics stay the same. In many cases, the economy receives a shock that it doesn’t
recover from over a very long time, so much so, that the economy seems entrapped in poverty. In
figure 1, we introduce a baseline scenario for countries with equal population sizes, while the initial
GDP and rate of capital accumulation are varied to capture the trend of disease prevalence and the
GDP for different degrees of contagiousness r≥ 1. When one of the two countries is rich or
developed, at smaller values of r, it takes the prevalence a longer time to reach its peak, and as a
result the epidemic lasts longer for both countries, figure 1a,b. With a moderate magnitude of
epidemics, the length of the epidemics has profound effect on economy. The reason is that a fast
growing epidemic triggers larger vaccination uptake (under the assumption that a vaccine is readily
available) and so the outbreak subsides faster and results in a resumption in economic development.
Slowly increasing epidemics, moderated by the waning nutrition and sanitation as economy drops,
may not be perceived to be as risky and fail to trigger vaccination uptake in the population, which
can affect the economy immensely in a negative feedback loop. In this case, at the beginning, moving
from less developed country 1 to the more developed country 2 is greater for better economic
opportunities, an effect magnified by low friction. But when both countries are initially at the same
economic status, the effect on the economy is less drastic but still significant if both were initially
poor, figure 1c,d. If both are rich countries they would be able to absorb the effect of the externality
and cross-border infection, figure 1e,f. This seems to be true due to their preparedness and
infrastructure that can deal with the outbreak magnitude, through sanitation, nutrition, and due to
less movement between the countries.
The effects of contagiousness changes as country 2 becomes 10 times larger than country 1, at least
when one of the two countries is poor. Only high levels of infectiousness can hurt the economic
development in the poor/rich and poor/poor situations, figure 2a,b. Disease spreads quickly and halts
quickly as well in poor/rich countries. But, disease hits the economy harder when both countries are



































































































































































































































































































Figure 3. Simulation of externality and cross-border infection of diseases when friction between countries are the same. Simulations
of GDP (in $1000) and disease prevalence for country 1 (a,c) and country 2 (b,d ) when an epidemic starts in country 1 with 10
initial cases, τ = 1000, k1(0) = 9 and k2(0) = 55, and N1(0) = N2(0) = 10
7. Fraction between countries are (a,b) F12 = F21 = 0.0178,







































poor and they could become even poorer if the disease takes a long time to cease, especially when it is
less infectious and so slowly spreading, figure 2c,d. If both countries are initially rich, then their economy
will not be affected as disease will find resistance to spread between people, figure 2e,f. A greater
population size in country 2 produces multiple waves of the epidemic in country 2 and spills back to
country 1 as well for moderate values of r (r = 1.75 or 2), figure 2e,f. Since the countries are richer and
have higher capital accumulation, the GDP remains unaffected by the degree of contagiousness, r.
Low friction between countries can cause damage to both economies worse than when the disease is
not very infectious, figure 3a,b. Along with the effect of higher friction between the two countries, figure
3c,d shows the disease externality and cross-border infection effects of diseases influences on the
economy in different ways. It looks as if it can affect the poor country to a greater degree, for high
infectiousness, if there is high friction rather than with low friction, figure 3a,c.
Health aid, from country 2 to country 1 can substantially save the economy of both countries,
figure 4a,b in contrast to figure 1a,b. Enhanced health aid from A = 105 to A = 106 from country 2 to
country 1, curbs the epidemic in country 1 by approximately 99.7% and saves them both from
externality, figure 4c,d. As a result, the economies of both countries grow steadily without disruption.
A lower cost of treatment as an intervention (τ = 100) shows that disease has less effect on economic
growth for both countries, figure 5a,b. However, in case of changing τ = 10 000, the GDP of both countries
almost collapse and take roughly 60 years to regain their initial GDPs, figure 5c,d. This can be the case of
severe transient poverty that both countries would face due to an extreme spread of infection even for
diseases with small transmission rates.
To understand the mutual effect of frictions, we simulated the model with δi = 0 for i = 1, 2, and
calculated the relative areas under the curve RAUC(ki|(F12, F12, r = r), (F12, F12, r = 1)) for i = 1, 2 and
r = 1.75, 2, 3. It seems that there are pairs of friction where the more contagious the disease is the worse
is the impact of the disease on the economy (the yellow coloured region in figure 6a–f ). There are also
some regions where the less contagious becomes worse (the dark blue coloured region in figure 6a–f ).
That might be also interpreted differently as that a decrease in effective contact rate, probably by
social distancing, might be a recipe for saving the economy. But that would not be a reasonable




























































































































































































































































































Figure 4. Simulation of externality and cross-border infection of diseases when aid is given from country 2 to country 1. Simulations
of GDP (in $1000) and disease prevalence for country 1 (a,c) and country 2 (b,d ) when an epidemic starts in country 1 with 10
initial cases, τ = 1000, k1(0) = 9 and k2(0) = 55, and N1(0) = N2(0) = 10
7. Aid from country 2 to country 1 is (a,b) A = 105, and







































solution due to the long time horizon of the disease endemic. We, however, calculated the relative areas
under the curve RAUC(ki|(F12, F12|A = 0), (F12, F12, A =A)) for i = 1, 2 and A = 10
5, 106 when r = 3,
figure 7a–d. The larger the aid, in which case 10% of the first country is regularly vaccinated, will lead
to similar results to decreasing contact by one-third, compare figures 6e,f and 7c,d.
The level of health aid and the timing have effects on the two countries’ economies. We examined the
effect of various times of starting the health aid programmes in the form of compulsory vaccination of
people in country 1. Long delays in sending health aid (vaccines) or not sending aid at all result in
loops that are due to the feedback cycle between disease and economy (figure 8a,b). A swift
significant response is required to mitigate the economical loss of both countries in which case GDP
and prevalence follow a regular inverted U-shaped function (figure 8a–d ). A slightly late response,
however, can still break through the loop, but to do so requires larger levels of aid (figure 8a–d ).
4. Discussion
An externality begins when an individual is involved in an activity that affects the welfare of others who
neither pay nor receive compensation for that activity. The existence of the externality is considered one
of the crucial factors in healthcare that influences disease patterns. An individual benefits from others
remaining healthy because it reduces the likelihood of disease transmission if the illness is contagious.
The presence of externality needs authorities to implement an intervention, such as mass vaccination.
A vaccinated person is less likely to be a disease carrier which prevents other individuals from
becoming ill [28]. People may choose whether to vaccinate or not under the cost–benefit analysis that
results in the externality within the healthcare system. The concept of externality is highly prevalent
in economics; however, it is not widely applied to the healthcare sector.
We developed a two-country disease-economy model to analyse the cross-country disease
propagation and its long-term effect on GDP. As a baseline scenario, we considered country 1 as a









































































































































































































































































r = 1 r = 1.75 r = 2 r = 3
r = 1 r = 1.75 r = 2 r = 3
(a) (b)
(c) (d)
r = 1 r = 1.75 r = 2 r = 3
r = 1 r = 1.75 r = 2 r = 3
Figure 5. Simulation of externality and cross-border infection of diseases at different costs of treatment. Simulations of GDP (in
$1000) and disease prevalence for country 1 (a,c) and country 2 (b,d ) when an epidemic starts in country 1 with 10 initial cases,
k1(0) = 9 and k2(0) = 55, and N1(0) = N2(0) = 10
7. Relative cost of treatment is (a,b) τ = 100, and (c,d ) τ = 104. Values of the rest







































poor country, where disease initiates and transmits to country 2 that is economically rich. In this scenario,
increasing the degree of contagiousness increases the number of infections that, in turn, contributes to
sharply declining GDPs for both countries. Countries do not regain their former GDP levels for 100
years. The countries are in a transient poverty state induced by chronic disease conditions, but they
reach their supposed level in a very long term, data are not shown. The GDP of country 2 deteriorates
due to externality since the infection that begin in country 1, and the GDP of country 1 worsens due
to the steady cross-border infection effect of the disease, but still in a transient poverty state. More
importantly, note that in figure 6a,c,e the larger the friction of movement from country 2 to country 1,
the more ameliorated the effect of the disease on the economy of country 1 is, due to the cross-border
infection effect. However, there is also lower friction that is also relatively less harmful to the
economy, but not necessarily in magnitude. There might be situations where externality and cross-
border infection have positive effects on eradicating the disease through modulated movements
between the two countries.
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Figure 6. Parameter planes for fractions F12 and F21 for different degrees of contagiousness. Parameter planes to show the relative
area under the curve of GDP (in $1000) when r = 1 to r = 1.75 in (a,b), r = 2 in (c,d ), and r = 3 in (e,f ). Relative area under the
curve of GDP (in $1000) for country 1 (a,c,e) and for country 2 (b,d,f ). In all of the calculations, epidemic starts in country 1 with 10
initial cases, k1(0) = 9 and k2(0) = 55, and N1(0) = N2(0) = 10
7. Relative cost of treatment is τ = 1000. The depreciation rates are







































We allowed each of the parameters to vary individually to observe the actual variation and impact of that
parameter to themodel prediction.We explored the result of our simulations by creating several scenarios and
economic conditions for two countries, such as both countries are poor, both countries are rich, and the
countries have differing economic status (one poor and one rich). Equal and reduced friction causes the
infection to grow higher, for even a small value of r, for both countries, as the huge flow of population
across the countries spreads the disease faster. On the other hand, we observed that curtailing or lowering
the friction establishes a ‘give and take’ situation for both countries since the visitation to another country
boosts its economy. Providing swift and substantial health aid, such as a supply of vaccine from country 2
to country 1 completely prevents the disease from appearing in the country that receives the vaccine. The
rate of transmission remains low, which allows the country to retain its stable prosperity in GDP
throughout the simulation time for both countries. We consider vaccination as a form of health aid, but it
could be one or a collection of measures of permanent health protection that have a synergistic effect.
The lower the value of relative price of treatment to vaccination τ, the better the growth of the countries’
GDP especially for low disease transmission rates. For higher τ values, the infection spreads with a
significantly higher peak number of infections with a large impact on the GDP. If the cost of treatment is
low it allows people to be able to treat themselves and recover faster where they stay relatively healthy,
even though many people get infected with a higher transmission rate of the disease. Those who recover
quickly minimize the loss of human capital which helps to protect their GDP from depreciating.
We have considered many variations on which we analysed the model from baseline scenario by
altering various parameter values, one at a time. The optimal strategies for both countries to adopt
may include, but are not limited to: reducing the friction through implementing soft immigration
rules between the countries; promoting nutrition and hygiene practices in different countries, helping
to improve sanitation infrastructure; providing medical support such as vaccines and vaccination
programme development from a richer country to a poorer country; and finding lower costs of
treatments over the cost of vaccinations.
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Figure 7. Parameter planes for fractions F12 and F21 for different levels of aid. Parameter planes to show the relative area under the
curve of GDP (in $1000) when r = 3 for A = 105 relative to A = 0 in (a,b), and A = 106 relative to A = 0 in (c,d ). Relative area under
the curve of GDP (in $1000) for country 1 (a,c) and for country 2 (b,d ). In all of the calculations, epidemic starts in country 1 with 10
initial cases, k1(0) = 9 and k2(0) = 55, and N1(0) = N2(0) = 10
7. Relative cost of treatment is τ = 1000. The depreciation rates are







































There are several limitations of our model, which future studies will consider. For example, in this
model, we used one disease to calibrate the model in which case the disease already existed. Also,
independent data are required to calibrate some parameters in the model, such as migration and
movement of people (e.g. tourism).
Future work will consider the strategic interactions between the two country’s health authorities with
game theory analysis. Also, our model is scalable, which allows us to consider multi-country scenarios to
analyse externality occurring between trading networks or trading blocs. It will more closely emulate
real-world situations about health externalities. More importantly, it is recommended in the future to
use neoclassical or endogenous growth models to depict the economic growth of the countries whose
households are the main decision makers in investment and disease mitigation, see [16,17]. Other
extensions of the current modelling study include investment decisions, policy choices and aid allocation.
5. Conclusion
Previous research shows strong correlation between perpetual poverty and endemic diseases. Poverty is
one of the greatest risk factors for acquiring diseases due to lack of infectious disease controls,
infrastructure and sanitation. Infectious disease can affect human capital, resulting in a poverty trap
making it difficult for individuals, and by extension entire countries, to escape perpetuating poverty.
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Figure 8. Health aid levels and timing. Phase diagram for per capita GDP ($1000) versus prevalence for country 1 in (a) and country 2
in (b). The black arrows show the general directions of the loops from left, then up, down, and finally going to the right. Parameter
planes to show the relative area under the curve of GDP (in $1000) when r = 3 for different combinations levels of annual health aid,
provided from country 2 to country 1, and their timing relative to A = 0 in (c,d ). The x-axis is for the time since the beginning of the
epidemic in country 1 (years) and the y-axis is for the annual vaccines received (provided) by country 1 (country 2) in (c) (in (d )).
Figures are shown for country 1 (a and c) and for country 2 (b and d ). In all of the calculations, epidemic starts in country 1 with 10
initial cases, k1(0) = 9 and k2(0) = 55, and N1(0) = N2(0) = 10
7. Relative cost of treatment is τ = 1000. The depreciation rates are







































This externality contributes to disease persistence and economic decline affecting others beyond the
disease outbreak itself.
Simulations from our model of the degree of infectiousness r show two main observations. First is
that, ceteris paribus, the degree of contagiousness r of diseases affects the economic development in
both countries in different ways depending on the demographics and economy strength but also on
the friction of moving between countries.
Second, health aid in terms of paid vaccines and logistic support for vaccine campaigns from a rich
country to another country with lower socio-economic status can help save both economies from
negative externality. Providing health aid, such as vaccination from one country to another
altruistically, offers protection to the recipient country with a positive effect on future GDP for both
countries. Often governments approach infectious disease management in a siloed manner focusing
efforts within their country only—failing to understand the porous nature of their borders to
infectious disease transmission through fomites, tourists and domestic travellers entering or leaving
the country transiently. Considering externality and incorporating it into health management suggests
providing health aid outside the nation state may result in better future economic outcomes through
reduced negative externality. Our results highlight the importance of externality in health systems and
the significant effect of health aid.
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Appendix A
A.1. Mathematical model
In the following, we consider two countries sharing a border through which there is influx and outflux of
residents who may interact within and between those two countries. We assume that the two populations
are otherwise closed.
A.2. SIR model
For the disease transmission dynamics, we use an SIR model. Let Si, Ii and Ri be the number of
susceptible, infectious and recovered people in country i, for i = 1, 2. Let Ni = Si + Ii +Ri be the total
population size of country i.
For each i = 1, 2 and j = 2, 1,
d
dt







 niSi (A 1Þ
d
dt








Ri ¼ gið1þ LiÞIi þ piSi  niRi, (A 3Þ
with Ii(0) = Ii,0 and Si(0) =Ni− Ii(0). And so
d
dt






























































then equations (A 1) and (A 2) become
d
dt




yi ¼ xiðli,iyi þ li,jy jÞ  gið1þ LiÞyi  miyi, (A 6Þ
where x = S/N and y = I/N, while R/N = 1− x− y makes the third equation in the transformed system of
ODE redundant.
A.3. Solow model
We use Solow model [29] to depict the economic growth in each country i and the spending on health
problem denoted by w, given as
d
dt
Ki ¼ ŝiFðKi, LiÞ  diKi  wðKiÞ: (A 7Þ
Based on the Cobb–Douglas production function F(Ki, Li) with constant returns to scale [30], the Solow
model of the GDP Ki is given by
d
dt
Ki ¼ ŝiKaii L1aii  diKi  ðCV  ðpiSiÞ þ CT  ðgiLiIiÞÞ þ ŝijTðKi=Ni, Ni; Kj=Nj, NjÞNj (A 8Þ
with Ki(0) =K0,i > 0. The number of available labour Li = Si +Ri + ℓ(Ki)Ii =Ni− (1− ℓ(Ki))Ii is made up
from the number of susceptible and recovered individuals in addition to a fraction ℓ(K) of infected
individuals who would have to work when the GDP is equal to K. The model incorporates the
following parameters: the elasticity coefficient αi > 0, depreciation rate δi > 0, rate of capital
accumulation due to production ŝi . 0 and rate of accumulation due to visiting ŝij . 0. The last term
in the Solow equation is the revenue due to the human traffic from country j. See below for definition
of the gravity function T.









0  ðm nÞK
N
and per capita GDP ($1000) is then given by the equation
d
dt




with l = 1 + (ℓ(k)− 1)y, and where cV(t) = CV(t)/1000, CT(t) = τ ∗CV(t), si ¼ ŝi=10001ai , and sij ¼ ŝij=1000.
Appendix B
B.1. Models parameters
All of the following parameters are functions in the per capita GDP ($1000) k.
— The birth and death rate are given via
mN ¼ m0ðkÞ ¼ 36306 7207 log k,
with R2 = 0.6857 and
nN ¼ n0ðkÞ ¼ 10676 937:8 log k,
with R2 = 0.1091 and so
mN  nN ¼ 25630 6269:2 log k,
and from equation (2.4)










































which can be used to find
mðkÞ ¼ 36306 7207 log k
Nð0Þ þ 25630t 6269:2 Ð t0 log kðsÞds
,
nðkÞ ¼ 10676 937:8 log k
Nð0Þ þ 25630t 6269:2 Ð t0 log kðsÞds
and mðkÞ  nðkÞ ¼ 25630 6269:2 log k
Nð0Þ þ 25630t 6269:2 Ð t0 log kðsÞds
,
which is negative for k > 59.6349.
Yet it is better to render equation (2.4) as
N0 ¼ 25630 6269:2 log kðtÞ, (B 1Þ
with the system and use
mðkðtÞÞ ¼ 36306 7207 log kðtÞ
NðtÞ ,
nðkðtÞÞ ¼ 10676 937:8 log kðtÞ
NðtÞ
and mðkðtÞÞ  nðkðtÞÞ ¼ 25630 6269:2 log kðtÞ
NðtÞ
for simulation and analysis.
— The within country transmission rate is
li,iðkiÞ ¼ l0rðsðkiÞÞ:
— The cross border transmission rate is
li,jðki, k jÞ ¼ l0Tðki, Ni; k j, NjÞrðsðkiÞÞ,
where λ0 is the basic contact rate and the visitations between country i and j, T(ki, Ni; kj, Nj), is the
spatial interaction modelled using the gravity model of immigration and trade, stemming from
Newton’s Law of universal gravitation [31],






where Fi,j is the friction (cost, distance, adjacency, common language, colonial link, etc.) between the
two countries for people coming from country j into country i. (See also [23,32–34].) The elasticity
constants of attraction due to GDP and friction are such that j0, j1, j2, j3 [ R.
— The probability of contracting the disease upon contact at sanitation s is
rðsðkÞÞ ¼ r0ð1 sðkÞÞ,
and let β0 = λ0ρ0 be the basic transmission rate, [25].
— The natural recovery rate is
gðkÞ ¼ gðnðkÞÞ ¼ g0nðkÞ:
See [25].
— The increase in recovery due to treatment is
LðkÞ ¼ L0ð1 expðfkÞÞ:
— The fraction of sick labour available in workforce is ℓ(k) where ℓ∈ [0, 1], with ℓ = 0 if sick people
cannot work.
— The cost of vaccination per person is changing over time due to inflation in prices happening at an
annualized inflation rate of f (assumed to be constant; however, see [35]) and is defined as
cVðtÞ ¼ cV,0ð1þ fÞt where 5  1000  cV,0  20:







































— The sanitation function is given by1
logit sðkÞ ¼ u0,s þ u1,s logðkÞ:
The parameters are estimated to be û0,s ¼ 2:6249, and û1,s ¼ 0:92, see [25].
— The nutrition function is given by
logit nðkÞ ¼ u0,n þ u1,n logðkÞ:
The parameters are estimated to be û0,n ¼ 1:1771, and û1,n ¼ 0:14, see [25].
— The probability to voluntarily vaccinate at time t is given by
piðtÞ ¼ u pyi:
B.1.1. External data
The following data were collected from Gapminder.com and analysed using Excel.
A scatter plot for the total birth number against the per capita GDP in $1000 for 160 countries for 2008
and the best fit curve are shown in figure 9a. It is estimated that
total birth number ¼ 7207 lnðk=1000Þ þ 36 306,
with coefficient of determination R2 ¼ 68:57%.
Similarly, a scatter plot for the total death number against the per capita GDP in $1000 for 160
countries for 2008 and the best fit curve are shown in figure 9b. It is estimated that
total death number ¼ 937:8 lnðk=1000Þ þ 10 676,
with coefficient of determination R2 ¼ 10:91%.
Appendix C
C.1. Model calibration
Calibration was done via fitting actual data of TB to the model. The goal, though, was not fitting the data
for validating the model as a TB, but rather to use some realistic parameter values. To do so, we used the
sums of squared differences between the actual and simulated values of the per capita GDP ($1000) and
the number of infected per 100 000. A genetic algorithm is used to find an optimal solution that
minimizes that sums of squares of errors.
Table 1 gives a set of plausible values for the set of parameters of the model.
Figure 10 shows that those values in table 1 can produce patterns similar to real evolution of diseases
and economic development in both countries. This does not mean that the changes in both countries’
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Figure 9. (a) Total birth number versus per capita GDP in $1000. (b) Total death number versus per capita GDP in $1000.
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